TP53 and cancer: Furthermore, oncogenic inactivation of p53/Lats2 and the liver kinase B1 (LKB1)/AMPK tumor suppressor axes, two most commonly observed genetic alterations in human cancer, abolish DVL’s function on YAP nuclear export.